Search research articles
Contact Us
Filters
Showing results (91-100 of 118) with videos related to
Page
of 12
Sort By:
British Journal of Cancer
|
July 15, 2010
The impact of lymph node density on survival of cervical cancer patients
S Polterauer, L Hefler, V Seebacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 1999
Serum concentrations of vascular endothelial growth factor in vulvar cancer
L Hefler, C Tempfer, A Obermair, et al.
Gynakologisch-Geburtshilfliche Rundschau
|
January 1, 1996
[Overexpression of p53 as prognosis factor in vulvar carcinoma]
P Kohlberger, G Breitenecker, G Gitsch, et al.
Cancer
|
November 15, 1995
Prognostic value of immunohistochemically detected p53 expression in vulvar carcinoma
P Kohlberger, C Kainz, G Breitenecker, et al.
Wiener Medizinische Wochenschrift (1946)
|
March 31, 1987
[Comparison of vaginosonographic, transabdominal sonographic and laparoscopic follicle puncture for the retrieval of oocytes within the scope of an in vitro fertilization program]
J Deutinger, P Riss, A Reinthaller, et al.
Fertility and Sterility
|
July 1, 1986
Pregnancy-specific parameters in early pregnancies after in vitro fertilization: prediction of the course of pregnancy
J Deutinger, J Neumark, A Reinthaller, et al.
International Journal of Cancer
|
June 17, 1999
Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer
L Hefler, A Obermair, C Tempfer, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
February 25, 2000
Serum concentrations of tissue polypeptide antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer
L Hefler, C Tempfer, K Frischmuth, et al.
Anticancer Research
|
September 3, 1999
P53 antibody response in patients with vulvar cancer
K Mayerhofer, L Hefler, M Schindl, et al.
Gynecologic Oncology
|
January 31, 2006
Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study
E Petru, L Angleitner-Boubenizek, A Reinthaller, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 118) with videos related to
Sort By:
Page
of 12
British Journal of Cancer
|
July 15, 2010
The impact of lymph node density on survival of cervical cancer patients
S Polterauer, L Hefler, V Seebacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 1999
Serum concentrations of vascular endothelial growth factor in vulvar cancer
L Hefler, C Tempfer, A Obermair, et al.
Gynakologisch-Geburtshilfliche Rundschau
|
January 1, 1996
[Overexpression of p53 as prognosis factor in vulvar carcinoma]
P Kohlberger, G Breitenecker, G Gitsch, et al.
Cancer
|
November 15, 1995
Prognostic value of immunohistochemically detected p53 expression in vulvar carcinoma
P Kohlberger, C Kainz, G Breitenecker, et al.
Wiener Medizinische Wochenschrift (1946)
|
March 31, 1987
[Comparison of vaginosonographic, transabdominal sonographic and laparoscopic follicle puncture for the retrieval of oocytes within the scope of an in vitro fertilization program]
J Deutinger, P Riss, A Reinthaller, et al.
Fertility and Sterility
|
July 1, 1986
Pregnancy-specific parameters in early pregnancies after in vitro fertilization: prediction of the course of pregnancy
J Deutinger, J Neumark, A Reinthaller, et al.
International Journal of Cancer
|
June 17, 1999
Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer
L Hefler, A Obermair, C Tempfer, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
February 25, 2000
Serum concentrations of tissue polypeptide antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer
L Hefler, C Tempfer, K Frischmuth, et al.
Anticancer Research
|
September 3, 1999
P53 antibody response in patients with vulvar cancer
K Mayerhofer, L Hefler, M Schindl, et al.
Gynecologic Oncology
|
January 31, 2006
Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study
E Petru, L Angleitner-Boubenizek, A Reinthaller, et al.
Page
of 12